ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SANJAY MADAN MD

3190 N MCMULLEN BOOTH RD SUITE 201

Clearwater | Florida | 33761

(727) 669-2969

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 3647

$1.03M Total Retail Price of All Prescriptions

Rank: 210 out of 3647

1,133 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,133 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 1,133 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 28,650 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 1,843 1,691 1 4
SIMVASTATIN 1,647 1,468 2 1
AMLODIPINE BESYLATE 1,280 1,177 3 2
OMEPRAZOLE 1,156 1,044 4 3
LEVOTHYROXINE SODIUM 916 841 5 5
FUROSEMIDE 839 750 6 8
HYDROCODONE-ACETAMINOPHEN 770 679 S3 7 12
METOPROLOL TARTRATE 696 656 8 7
HYDROCHLOROTHIAZIDE 665 642 9 9
ALLOPURINOL 651 572 10 37
ALENDRONATE SODIUM 616 573 11 23
METFORMIN HCL 586 500 12 6
ATORVASTATIN CALCIUM 574 511 13 13
LOSARTAN POTASSIUM 568 549 14 11
ALPRAZOLAM 528 432 15 31
ATENOLOL 521 509 16 10
SERTRALINE HCL 466 415 17 27
CRESTOR 458 393 18 19
METOPROLOL SUCCINATE 424 365 19 18
CARVEDILOL 408 387 20 20
WARFARIN SODIUM 397 364 21 15
ZOLPIDEM TARTRATE 387 348 22 14
GLIMEPIRIDE 354 327 23 45
MELOXICAM 340 316 24 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 317 291 25 36
LOVASTATIN 306 299 26 21
LEVOFLOXACIN 301 256 27 87
CLOPIDOGREL 298 288 28 26
ENALAPRIL MALEATE 297 257 29 35
TAMSULOSIN HCL 272 259 30 28
DOXAZOSIN MESYLATE 264 253 31 57
PLAVIX 255 250 32 39
POTASSIUM CHLORIDE 255 209 32 24
TEMAZEPAM 251 206 34 47
DONEPEZIL HCL 247 244 35 30
FLUOXETINE HCL 246 220 36 68
IBUPROFEN 241 211 37 55
PANTOPRAZOLE SODIUM 231 181 38 38
ISOSORBIDE MONONITRATE ER 223 207 39 56
DIGOXIN 204 172 40 51
GABAPENTIN 204 167 40 17
SYNTHROID 203 194 42 42
GEMFIBROZIL 197 147 43 82
PROAIR HFA 197 173 43 62
NAPROXEN 192 171 45 70
PREDNISONE 191 171 46 43
CIPROFLOXACIN HCL 191 181 46 53
TESTOSTERONE CYPIONATE 186 175 S3 10 48 280
GLIPIZIDE 179 154 49 41
GLYBURIDE 164 153 R 50 54
TRAMADOL HCL 162 122 51 22
VIAGRA 161 146 52 69
PRAVASTATIN SODIUM 158 154 53 16
AZITHROMYCIN 150 123 54 34
CEFUROXIME 147 128 55 228
ADVAIR DISKUS 144 122 56 52
LORAZEPAM 139 117 57 73
CITALOPRAM HBR 139 116 57 25
LANTUS 137 99 59 59
OXYBUTYNIN CHLORIDE 135 123 60 107
JANTOVEN 127 127 61 140
VENTOLIN HFA 125 102 62 88
INSULIN SYRINGE 123 107 63 76
TERAZOSIN HCL 122 122 64 103
DIAZEPAM 116 97 65 214
TRAZODONE HCL 114 78 66 64
OXYCODONE-ACETAMINOPHEN 108 62 S2 67 91
PAROXETINE HCL 105 87 68 60
VERAPAMIL ER 101 97 69 99
FINASTERIDE 100 100 70 66
DILTIAZEM ER 100 84 70 167
RANITIDINE HCL 97 80 72 29
SPIRONOLACTONE 97 61 72 77
NAMENDA 95 92 74 49
DILTIAZEM 24HR ER 89 74 75 164
DOXYCYCLINE HYCLATE 89 77 75 145
NASONEX 84 66 77 220
AMITRIPTYLINE HCL 84 53 R 77 105
FENOFIBRATE 83 70 79 50
OXYCODONE HCL 82 43 S2 80 75
MORPHINE SULFATE ER 78 62 S2 81 163
CLONIDINE HCL 77 65 82 46
TRIAMTERENE-HCTZ 77 65 82 58
MECLIZINE HCL 72 65 84 85
FLUTICASONE PROPIONATE 70 66 85 32
CARTIA XT 69 69 86 242
TIZANIDINE HCL 67 44 87 126
PROPRANOLOL HCL 66 55 88 156
CEPHALEXIN 65 62 89 142
CLOTRIMAZOLE-BETAMETHASONE 64 54 90 84
SPIRIVA 63 54 91 93
CELEBREX 62 48 92 111
METRONIDAZOLE 62 57 92 247
FLECAINIDE ACETATE 61 54 94 556
BENAZEPRIL HCL 61 59 94 71
NITROSTAT 60 57 96 206
RAMIPRIL 59 49 97 101
METHYLPREDNISOLONE 58 43 98 78
MIRTAZAPINE 58 49 98 63
TORSEMIDE 58 34 98 215
ESCITALOPRAM OXALATE 58 37 98 65
FAMOTIDINE 57 57 102 61
RISPERIDONE 56 54 103 83
LEVOXYL 53 53 104 125
DILTIAZEM 24HR CD 53 52 104 155
AMIODARONE HCL 53 45 104 211
HYDRALAZINE HCL 53 48 104 81
LACTULOSE 52 36 108 128
VENLAFAXINE HCL ER 51 33 109 181
JANUVIA 51 50 109 72
BACLOFEN 50 20 111 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.